ARTICLE | Clinical News
Serono Laboratories Inc. regulatory update
November 20, 1995 8:00 AM UTC
The company's Serostim, a mammalian cell-derived recombinant human growth hormone, received priority review status from the FDA to treat AIDS wasting in adults. In clinical trials, Serono said patien...